telehealth glp-1 crackdown news The growing availability of compounded weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration US FDA sends 25 letters

While hexavalent chromium is a known human carcinogen, and it has become widespread in the environment, the impact of environmental contamination with this element are not known

Individuals with autoimmune conditions, active malignancy, or severe organ dysfunction should obtain explicit clearance

van Bmmel F, Stein K, Heyne R, Petersen J, Buggisch P, Berg C, Zeuzem S, Stallmach A, Sprinzl M, Schott E, Pathil-Warth A, von Arnim U, Keitel V, Lohmeyer J, Simon KG, Trautwein C, Trein A, Hppe D, Cornberg M, Lammert F, Ingiliz P, Zachoval R, Hinrichsen H, Zipprich A, Klinker H, Schulze Zur Wiesch J, Schmiedeknecht A, Brosteanu O, Berg T

[136] In May 2018, Lilly acquired Armo Biosciences for $1.6 billion, obtaining the white blood cell-boosting cancer treatment candidate pegilodecakin